Proven Success with GxP Systems
Strategic partnerships with industry-leaders help alleviate facility design/build and launch constraints. With $1B in GxP project experience, cGMPnow brings the right solution to you, faster.
Meet the Leadership Team
Jeff Gilmore, PE PMP
Chief Executive Officer
Jeff has over thirty years of diversified large capital project management, process design, construction management, and CQV experience in the pharmaceutical and biopharmaceutical industry. His experience spans from scale-up of early development products all the way through to commercial launch of biopharma products.
Dan Swanson, PE PMP
Chief Business Officer
Dan has nearly thirty years of Project Management and Process Engineering experience in the pharmaceutical and biopharmaceutical industry with significant experience in Cell & Gene Therapy facility design.
Grayson Heller
Chief Operations Officer
Grayson has over 18 years of process/project engineering and project management experience in the pharmaceutical, biotechnology and specialty chemical industries. He earned his ChemE from the University of Colorado and has worked directly for Roche, CH2M Hill, and Sandoz in a variety of roles including system owner.
Jason Parker
Director Project Management
Chris Herskovits
Director Engineering
Lets make a real difference together.
Jeff Gilmore, PE PMP
Chief Executive Officer
Jeff has over thirty years of diversified large capital project management, process design, construction management, and CQV experience in the pharmaceutical and biopharmaceutical industry. His experience spans from scale-up of early development products all the way through to commercial launch of biopharma products. He has a strong acumen for providing leadership of diverse project executions team.He is a founding member of Vista Engineering Group and has an extensive and diverse background in large capital project planning and execution for cGMP biologics and pharma manufacturing facilities. Jeff is a subject matter expert for Advanced Therapy Medicinal Products (ATMPs) manufacturing facility design, manufacturing processes, and GMP-readiness.
Dan Swanson, PE PMP
Chief Business Officer
Dan has nearly thirty years of Project Management and Process Engineering experience in the pharmaceutical and biopharmaceutical industry with significant experience in Cell & Gene Therapy facility design.
He has helped start two successful engineering consulting firms and has an extensive and diverse background in a broad range of engineering disciplines, with particular strengths in Project Execution in an FDA regulated cGMP environment.
Most recently Dan has been serving as Chief Business Officer at cGMPnow overseeing the day-to-day Business Operations division and assisting with early stage due diligence and facility conceptual design, cost & schedule estimation.
Grayson Heller
Chief Operations Officer
Grayson has over 18 years of process/project engineering and project management experience in the pharmaceutical, biotechnology and specialty chemical industries. He earned his ChemE from the University of Colorado and has worked directly for Roche, CH2M Hill, and Sandoz in a variety of roles including system owner.
As a founding member of Vista Engineering Group, Grayson has spent the last 6 years supporting clients including Amgen, AstraZeneca and Novartis as well as other industry leaders that are heavily cGMP & FDA regulated. He has also played a significant role in multiple start-up companies such as STAQ Pharma, AveXis, MycoTechnology, ION Engineering and ZS Pharma, providing technical leadership and strategy, project engineering and project management. Grayson has a BS in Chemical Engineering from the University of Colorado Boulder.
cGMP now was founded on the premise to accelerate gene & cell therapy products to patients. Grayson and the team have focused efforts on providing state-of-the-art gene & cell therapy facilities by bringing to the table the world class experience demanded by this industry.
